American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings-Reference-Cited by-同舟云学术

American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings

Published:2022-05 Issue:5 Volume:28 Page:528-562
ISSN:1530-891X
Container-title:Endocrine Practice
language:en
Short-container-title:Endocrine Practice

Author:

Cusi Kenneth,Isaacs Scott,Barb Diana,Basu Rita,Caprio Sonia,Garvey W. Timothy,Kashyap Sangeeta,Mechanick Jeffrey I.,Mouzaki Marialena,Nadolsky Karl,Rinella Mary E.,Vos Miriam B.,Younossi Zobair

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference384 articles.

1. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes;Younossi;Hepatology,2016

2. Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis;Younossi;Hepatology,2018

3. Endpoints and clinical trial design for nonalcoholic steatohepatitis;Sanyal;Hepatology,2011

4. Design and validation of a histological scoring system for nonalcoholic fatty liver disease;Kleiner;Hepatology,2005

5. Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort;Harrison;J Hepatol,2021

Cited by 478 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methods and validation of velacur determined fat fraction in patients with MASLD;WFUMB Ultrasound Open;2024-12

2. Chiglitazar attenuates high-fat diet-induced nonalcoholic fatty liver disease by modulating multiple pathways in mice;Molecular and Cellular Endocrinology;2024-11

3. Efectos cardiometabólicos de la pérdida de peso;Atención Primaria;2024-10

4. Fibrosis-4 score for screening of metabolic dysfunction-associated steatotic liver disease (MASLD): Data from a population-based sample in Tuscany;Nutrition, Metabolism and Cardiovascular Diseases;2024-10

5. Nutritional diagnoses and interventions in people with metabolic dysfunction-associated fatty liver disease:Cross-sectional study;Clinical Nutrition Open Science;2024-10